168 related articles for article (PubMed ID: 6188300)
1. [Cell-free Pseudomonas vaccine. III. Immunochemical analysis of purified Pseudomonas aeruginosa protein antigens and protective properties of antisera against these antigens].
Chekan LV; Stanislavskiĭ ES; Polkina NA
Zh Mikrobiol Epidemiol Immunobiol; 1983 Feb; (2):92-6. PubMed ID: 6188300
[TBL] [Abstract][Full Text] [Related]
2. [Immunochemical analysis of water-soluble antigen complexes isolated from typing strains of Pseudomonas aeruginosa of different O-serogroups].
Chekan LV; Stanislavskiĭ ES
Zh Mikrobiol Epidemiol Immunobiol; 1980 Dec; (12):49-54. PubMed ID: 6784418
[TBL] [Abstract][Full Text] [Related]
3. [Cell-free pseudomonas vaccine. I. Enzyme properties and virulence of strains of P. aeruginosa; protective activity of their water-soluble antigens].
Stanislavskiĭ ES; Zhvanetskaia MI; Mashilova GM; Gladus MA
Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):66-72. PubMed ID: 6778035
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
5. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
[TBL] [Abstract][Full Text] [Related]
6. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
7. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM
Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
[TBL] [Abstract][Full Text] [Related]
8. [Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum].
Podgornaia LG; Dziuban NF
Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):67-9. PubMed ID: 3092510
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies on the protective potential of antisera directed against four antigenic preparations from Pseudomonas aeruginosa.
Johnston LJ; Syeklocha D
Can J Microbiol; 1972 Oct; 18(10):1607-11. PubMed ID: 4628185
[No Abstract] [Full Text] [Related]
10. Antigenic relationship between the common antigen (OEP) of Pseudomonas aeruginosa and Vibrio cholerae.
Hirao Y; Homma JY
Infect Immun; 1978 Feb; 19(2):373-7. PubMed ID: 75846
[TBL] [Abstract][Full Text] [Related]
11. [Protective action of a corpuscular polyvalent Pseudomonas aeruginosa vaccine against representative enterobacteria].
Vetkova LG; Antsiferova NG; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):26-30. PubMed ID: 2409719
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.
Hatano K; Boisot S; DesJardins D; Wright DC; Brisker J; Pier GB
Infect Immun; 1994 Sep; 62(9):3608-16. PubMed ID: 7520416
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical and immunological study of cell-wall proteins of Pseudomonas aeruginosa.
Stanislavsky ES; Edvabnaya LS; Zaidher IG; Makarenko TA; Bulk VF; Zhvanetskaya MI; Mashilova GM
Acta Microbiol Hung; 1986; 33(3):245-55. PubMed ID: 3105226
[TBL] [Abstract][Full Text] [Related]
14. A new polyvalent pseudomonas vaccine.
Merle P; Robbel L; Hungerer KD
Behring Inst Mitt; 1984 Nov; (76):113-20. PubMed ID: 6441560
[TBL] [Abstract][Full Text] [Related]
15. [Immunologic study of the cellular components of bacillus pyocyaneus. V. Antigenic analysis of slime and its fractions].
Zaĭdner IG; Stanislavskiĭ ES; Kolker II; Grishina IA; Palkina NA
Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):41-5. PubMed ID: 91285
[TBL] [Abstract][Full Text] [Related]
16. An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification.
Berche P; Véron M; Fermanian J; Daoulas-Lebourdelles F; Guégen A
Ann Microbiol (Paris); 1979; 130(2):179-88. PubMed ID: 90473
[TBL] [Abstract][Full Text] [Related]
17. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. III. Polyvalent serum against three mucoid immunotypes potentiates phagocytosis of all (7) mucoid immunotypes.
Gościniak G; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1988; 36(2):195-203. PubMed ID: 3149178
[TBL] [Abstract][Full Text] [Related]
18. [Obtaining of outer membrane protein I of Pseudomonas aeruginosa and assessment of its antigenic properties].
Gatypova EV; Zlygostev SA; Kaloshin AA; Mikhaĭlova NA
Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):50-3. PubMed ID: 19189463
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis.
Lam JS; Mutharia LM; Hancock RE; Høiby N; Lam K; Baek L; Costerton JW
Infect Immun; 1983 Oct; 42(1):88-98. PubMed ID: 6194119
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
Iushkova NA; Stanislavskiĭ ES; Landsman NM
Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
